Schedule 13G ownership disclosure

CYTOSORBENTS CORP

Common Stock · CUSIP: 23283X206

Event date: 2025-03-31

Filing-level shares
1,949,551
Percent of class
3.11%
  • The Vanguard Group

    Shares: 1,949,551 · Class: 3.11%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000508
Form type
SCHEDULE 13G/A
Filer
Cytosorbents Corp
CIK
CIK 1175151
Filed
Apr 30, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub